Patient characteristics, burden of disease, healthcare resource utilization and costs in acute myeloid leukemia - a retrospective observational study with German claims data.

ABSTRACT: Aim: To assess patient characteristics, burden of disease, healthcare resource utilization and costs of acute myeloid leukemia (AML) by treatment intensity in German claims data. Materials & methods: In this retrospective cohort study using claims data from the German sickness fund AOK PLUS, we identified incident AML patients between 2012 and 2022. Incident AML patients were stratified into groups receiving intensive chemotherapy (IC) or nonintensive therapy (NIC). We then conducted descriptive analyses of patient characteristics, disease burden, including blood and platelet transfusions, healthcare resource utilization and costs. Results: We identified 1533 incident AML patients who received treatment (male: 53%; mean age: 67.7 years; median Charlson comorbidity inde

SUBMITTER: Greth K 

PROVIDER: S-EPMC12711103 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature